111 related articles for article (PubMed ID: 38008395)
1. Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma.
Sui Q; Hu Z; Liang J; Lu T; Bian Y; Jin X; Li M; Huang Y; Yang H; Wang Q; Lin Z; Chen Z; Zhan C
Cancer Lett; 2024 Jan; 581():216497. PubMed ID: 38008395
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide elicits anti-tumor activity by inhibiting polarization of M2-like tumor-associated macrophages via Notch signaling pathway in lung adenocarcinoma.
Yin JZ; Shi XQ; Wang MD; Du H; Zhao XW; Li B; Yang MH
Int Immunopharmacol; 2023 Apr; 117():109899. PubMed ID: 36827926
[TBL] [Abstract][Full Text] [Related]
3. A2aR on lung adenocarcinoma cells: A novel target for cancer therapy via recruiting and regulating tumor-associated macrophages.
Bai Y; Zhang X; Zhou J; Guo J; Liu Y; Liang C; Wang W; Xing Y; Wu J; Hu D
Chem Biol Interact; 2023 Sep; 382():110543. PubMed ID: 37263557
[TBL] [Abstract][Full Text] [Related]
4. M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942.
Wei K; Ma Z; Yang F; Zhao X; Jiang W; Pan C; Li Z; Pan X; He Z; Xu J; Wu W; Xia Y; Chen L
Cancer Lett; 2022 Feb; 526():205-216. PubMed ID: 34838826
[TBL] [Abstract][Full Text] [Related]
5. Metformin is a potential therapeutic for COVID-19/LUAD by regulating glucose metabolism.
Hou Y; Yang Z; Xiang B; Liu J; Geng L; Xu D; Zhan M; Xu Y; Zhang B
Sci Rep; 2024 May; 14(1):12406. PubMed ID: 38811809
[TBL] [Abstract][Full Text] [Related]
6.
Liang L; He H; Jiang S; Liu Y; Huang J; Sun X; Li Y; Jiang Y; Cong L
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142328
[No Abstract] [Full Text] [Related]
7. LncRNA LINC00680 promotes lung adenocarcinoma growth via binding to GATA6 and canceling GATA6-mediated suppression of SOX12 expression.
Sun X; Wang R; Tan M; Tian X; Meng J
Exp Cell Res; 2021 Aug; 405(1):112653. PubMed ID: 34029572
[TBL] [Abstract][Full Text] [Related]
8. Single-cell profiling reveals the trajectory of FOLR2-expressing tumor-associated macrophages to regulatory T cells in the progression of lung adenocarcinoma.
Xiang C; Zhang M; Shang Z; Chen S; Zhao J; Ding B; Jiang D; Zhu Q; Teng H; Zhu L; Shao J; Zhao R; Ye M; Yu Y; Han Y
Cell Death Dis; 2023 Aug; 14(8):493. PubMed ID: 37532692
[TBL] [Abstract][Full Text] [Related]
9. Identification of eIF6 as a prognostic factor that drives tumor progression and predicts arsenic trioxide efficacy in lung adenocarcinoma.
Shen Y; Zhang R; Li X
Mol Biol Rep; 2023 Feb; 50(2):1167-1180. PubMed ID: 36435920
[TBL] [Abstract][Full Text] [Related]
10. Exosomes from M1-polarized macrophages promote apoptosis in lung adenocarcinoma via the miR-181a-5p/ETS1/STK16 axis.
Wang X; Huang R; Lu Z; Wang Z; Chen X; Huang D
Cancer Sci; 2022 Mar; 113(3):986-1001. PubMed ID: 35092121
[TBL] [Abstract][Full Text] [Related]
11. Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma.
Liu Y; Ye G; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Dong B; Qi Y
Aging (Albany NY); 2020 Nov; 12(21):21559-21581. PubMed ID: 33170151
[TBL] [Abstract][Full Text] [Related]
12. Thymosin β10 promotes tumor-associated macrophages M2 conversion and proliferation via the PI3K/Akt pathway in lung adenocarcinoma.
Zeng J; Yang X; Yang L; Li W; Zheng Y
Respir Res; 2020 Dec; 21(1):328. PubMed ID: 33349268
[TBL] [Abstract][Full Text] [Related]
13. AGRN promotes lung adenocarcinoma progression by activating Notch signaling pathway and acts as a therapeutic target.
Zhang H; Liang J; Lu T; Li M; Shan G; Bi G; Zhao M; Jin X; Wang Q; Chen Z; Zhan C
Pharmacol Res; 2023 Aug; 194():106819. PubMed ID: 37321467
[TBL] [Abstract][Full Text] [Related]
14. miR-15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2.
Wang J; Yao S; Diao Y; Geng Y; Bi Y; Liu G
Thorac Cancer; 2020 Jun; 11(6):1396-1405. PubMed ID: 32220063
[TBL] [Abstract][Full Text] [Related]
15. Regulating autophagy facilitated therapeutic efficacy of the sonic Hedgehog pathway inhibition on lung adenocarcinoma through GLI2 suppression and ROS production.
Fan J; Zhang X; Wang S; Chen W; Li Y; Zeng X; Wang Y; Luan J; Li L; Wang Z; Sun X; Shen B; Ju D
Cell Death Dis; 2019 Aug; 10(9):626. PubMed ID: 31427566
[TBL] [Abstract][Full Text] [Related]
16. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
Ren P; Hong X; Chang L; Xing L; Zhang H
Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
[TBL] [Abstract][Full Text] [Related]
17. Histone lysine methyltransferase SETDB2 suppresses NRF2 to restrict tumor progression and modulates chemotherapy sensitivity in lung adenocarcinoma.
Yuan G; Hu B; Ma J; Zhang C; Xie H; Wei T; Yang Y; Ni B
Cancer Med; 2023 Mar; 12(6):7258-7272. PubMed ID: 36504353
[TBL] [Abstract][Full Text] [Related]
18. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L
Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009
[TBL] [Abstract][Full Text] [Related]
19. Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells.
Yin X; Han S; Song C; Zou H; Wei Z; Xu W; Ran J; Tang C; Wang Y; Cai Y; Hu Q; Han W
Cell Oncol (Dordr); 2019 Aug; 42(4):459-475. PubMed ID: 31001733
[TBL] [Abstract][Full Text] [Related]
20. LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2.
Han S; Cao D; Sha J; Zhu X; Chen D
Mol Oncol; 2020 May; 14(5):1074-1088. PubMed ID: 31919993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
